Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228007 · ClinicalTrials.gov registry record · Phase 3
Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users
A Phase 3 study, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 265
- Enrollment target
NCT00228007 is a Phase 3 study that has completed, run by Butler Hospital. The registered enrollment target is 265 participants.
The verdict
NCT00228007, a Phase 3 study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 265 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of antidepressant medication treatment in reducing HIV risk behaviors in intravenous drug users with depression.
Interventions
- DRUG Antidepressant Medication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2000-09 |
| Est. Completion | 2004-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00228007
The ClinicalTrials.gov registry entry for NCT00228007 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Antidepressant Medication is the first listed.
NCT00228007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00228007 about?
NCT00228007 is a clinical study titled "Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users". This study will evaluate the effectiveness of antidepressant medication treatment in reducing HIV risk behaviors in intravenous drug users with depression.
What is the current status of trial NCT00228007?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 265 participants. The study started on 2000-09. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00228007?
The interventions under investigation include: Antidepressant Medication (DRUG).
Who is sponsoring clinical trial NCT00228007?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.